Charles River

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.

CEO

Birgit Girshick

CEOBirgit Girshick

Employees

19,700

Employees19,700

Headquarters

Wilmington, Massachusetts

HeadquartersWilmington, Massachusetts

Founded

1947

Founded1947

Employees

19,700

Employees19,700

CRL Key Statistics

Market cap

16.34B

Market cap16.34B

Price-Earnings ratio

379.84

Price-Earnings ratio379.84

Dividend yield

—

Dividend yield—

Average volume

1.27M

Average volume1.27M

High today

$344.00

High today$344.00

Low today

$326.29

Low today$326.29

Open price

$336.38

Open price$336.38

Volume

895.08K

Volume895.08K

52 Week high

$379.63

52 Week high$379.63

52 Week low

$146.20

52 Week low$146.20

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $340.81. The company's market cap stands at 16.34B, with a P/E ratio of 379.84.

On 2026-11-13, Charles River(CRL) stock moved within a range of $326.29 to $344.00. With shares now at $340.81, the stock is trading +4.5% above its intraday low and -0.9% below the session's peak.

Trading activity shows a volume of 895.08K, compared to an average daily volume of 1.27M.

The stock's 52-week range extends from a low of $146.20 to a high of $379.63.

CRL News

Simply Wall St 14h

Charles River Climbed 100% While Sales Fell - Simply Wall St

...

Simply Wall St 2d

Why Charles River Laboratories International's Earnings Are Better Than They Seem

Charles River Laboratories International, Inc.'s ( ) solid earnings announcement recently didn't do much to the stock price. We did some digging, and we think t...

Benzinga 3d

Charles River Laboratories Recent $470 Million Deal an 'Attractive Strategic Addition,' Analyst Says

Charles River Laboratories International Inc. (NYSE:CRL) on Monday agreed to acquire the bioanalysis and drug metabolism and pharmacokinetics (DMPK) operations...

Analyst ratings

74%

of 19 ratings

Buy

73.7%

Hold

15.8%

Sell

10.5%

More CRL News

Seeking Alpha 4d

Charles River to acquire Frontage's bioanalysis and DMPK operations for $470M cash

Charles River to acquire Frontage's bioanalysis and DMPK operations for $470M cash Nov 09, 2026, 6:40 AM ET Charles River Laboratories International, Inc. (CRL)...

TipRanks 4d

Charles River Laboratories Earnings Call Signals Strong Recovery

Charles River Laboratories Intl ((CRL)) has held its Q3 earnings call. Read on for the main highlights of the call. Charles River Laboratories delivered a broa...

Simply Wall St 5d

Charles River Stock In Focus After Higher EPS Guidance And Tax Reserve Reversal

Charles River Laboratories International raised its 2026 GAAP EPS guidance to US$8.15 to US$8.35, citing a third quarter benefit from reversing acquired tax res...

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Salesforce

Moderna

Thermo Fisher Scientific

PayPal

Micron Technology

Eli Lilly

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.